Apex Biotechnology Corp.
1733.TW
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.04B
Close$
Share Statistics
| Market cap | $3.04 Billion |
|---|---|
| Enterprise Value | $2.46 Billion |
| Dividend Yield | $1.30 (4.27%) |
| Earnings per Share | $1.63 |
| Beta | 0.26 |
| Outstanding Shares | 100,453,000 |
Return
| Return on Equity | 10.25% |
|---|---|
| Return on Assets | 7.47% |
| Return on Invested Capital | 8.58% |
Valuation & Multiples
| P/E Ratio | 16.03 |
|---|---|
| PEG | 56.03 |
| Price to Sales | 1.69 |
| Price to Book Ratio | 1.69 |
| Enterprise Value to Revenue | 1.32 |
| Enterprise Value to EBIT | 14.64 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$0.50
Average shareholder expectationRevenue Estimate
$636.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.50
Average shareholder expectationRevenue Estimate
$636.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Apex Biotechnology Corp.
641 employees
CEO: Yanshi Shen Apex Biotechnology Corp. is a Taiwanese firm that specializes in the global development, manufacturing, and distribution of medical devices designed for home use, all powered by sophisticated biosensor technology. Their comprehensive pro...